Skip to main content

Part of the book series: Serono Symposia, USA ((SERONOSYMP))

  • 94 Accesses

Abstract

Increasingly, variant forms of growth hormone are being found, but an understanding of their significance has not kept pace with the ability to detect them. One of the problems is that the variants occur in much lower concentrations than the major form, thus making preparation of quantities for biologic testing a difficult task. In addition, availability of human pituitary glands for such studies was limited until recently, when clinical treatment with pituitary-derived growth hormone was discontinued and the glands became available for research projects concerned with identification of new substances. The low concentration of many of the forms raises a frequently asked question: can these forms have physiologic relevance when they occur in such small amounts compared to the major form? What is usually overlooked here is the fact that the major form occurs in an enormous quantity compared to the other pituitary hormones. A comparison of human pituitary hormones will illustrate this point. There are between 5000 and 7000 yg of the major form of human growth hormone (hGH) in a pituitary gland. If the concentration of a variant of hGH is 1% or this (50 to 70 yg), its concentration would be similar to that of FSH; a 3% concentration would equal the amount of prolactin in a gland.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Davis RB, Morris J, Ivarie R. The polypeptide P16 is a carboxy terminal cleavage product of rat growth hormone in anterior pituitary and GH- pituitary tumor cells. Mol Endocrinol 1987; 1: 102.

    Article  PubMed  CAS  Google Scholar 

  2. Sinha YN, Gilligan TA. A “20K” form of growth hormone in the murine pituitary gland. Proc Soc Exp Biol Med 1984; 177: 465.

    PubMed  CAS  Google Scholar 

  3. Yokoya A, Friensen HG. Human growth hormone (GH)-releasing factor stimulates and somatostatin inhibits the release of rat GH variants. Endocrinology 1986; 119: 2097.

    Google Scholar 

  4. Seeburg PH. The human growth hormone gene family: nucleotide sequences show recent divergence and predict a new polypeptide hormone. DNA 1982; 1: 239.

    Article  PubMed  CAS  Google Scholar 

  5. Frankenne F, Rentier-Delrue F, Scippo M-L, Martial J, Hennen G. Expression of the growth hormone variant gene in human placenta. J Clin Endocrinol Me tab 1987; 64: 635.

    Article  CAS  Google Scholar 

  6. Chien Y-H, Thompson EB. Genomic organization of rat prolactin and growth hormone genes. Proc Natl Acad Sci USA 1980; 77: 4583.

    Article  PubMed  CAS  Google Scholar 

  7. DeNoto FM, Moore DD, Goodman HM. Human growth hormone DNA sequence and mRNA structure: possible alternative splicing. Nucleic Acids Res 1981; 9: 3719.

    Article  PubMed  CAS  Google Scholar 

  8. Wallis M. Growth hormone: deletions in the protein and introns in the gene. Nature 1980; 284: 512.

    Article  PubMed  CAS  Google Scholar 

  9. Lewis UJ, Bonewald LF, Lewis LJ. The 20,000-dalton variant of human growth hormone: location of the amino acid deletion. Biochem Biophys Res Commun 1980; 92: 511.

    Article  PubMed  CAS  Google Scholar 

  10. Baumann G, MacCart JG, Ambrun K. The molecular nature of circulating growth hormone in normal and acromegalic man: evidence for a principal and minor monomeric form. J Clin Endocrinol Metab 1983; 56: 946.

    Article  PubMed  CAS  Google Scholar 

  11. Sinha YN, Gilligan TA, Lee DW, Baxi SC, VanderLaan WP. Demonstration of 20K growth hormone in human plasma by gel electrophoretic-immuno- staining-autoradiographic assay (GEISAA). Horm Metab Res 1986; 18: 402.

    Article  PubMed  CAS  Google Scholar 

  12. Markoff E, Lee DW, Culler FL, Jones KL, Lewis UJ. Release of the 22,000- and the 20,000-dalton variants of growth hormone in vivo and in vitro by human anterior pituitary cells. J Clin Endocrinol Metab 1986; 62: 664.

    Article  PubMed  CAS  Google Scholar 

  13. Hampson RK, Rottman FM. A potential variant of bovine growth hormone resulting from non-splicing of an intron. Fed Proc 1986; 45: 1703.

    Google Scholar 

  14. Singh RNP, Seavey BK, Rice VP, Lindsey TT, Lewis UJ. Modified forms of human growth hormone with increased biological activities. Endocrinology 1974; 94: 883.

    Article  PubMed  CAS  Google Scholar 

  15. Yadley RA, Chrambach A. Isohormones of human growth hormone. II. Plasmin-catalyzed transformation and increase in prolactin biological activity. Endocrinology 1973; 93: 858.

    Article  PubMed  CAS  Google Scholar 

  16. Singh RNP, Seavey BK, Lewis LJ, Lewis UJ. Human growth hormone peptide 1–43: isolation from pituitary glands. J Prot Chem 1983; 2: 425.

    Article  CAS  Google Scholar 

  17. Frigeri LG, Teguh K, Wehrenberg WB, Ling N, Lewis UJ. Enhancement of insulin action by NH-terminal peptides of growth hormone [Abstract]. Clin Res 1986; 34: 103A.

    Google Scholar 

  18. Frigeri LG, Ling N, Rudman C, VanderLaan WP, Lewis UJ. Increased in vivo glucose utilization by amino terminal peptides of growth hormone [Abstract]. Burlington, Vermont: Research Symposium of Diabetes and Exercise, July, 1983.

    Google Scholar 

  19. Lewis UJ, Peterson SM, Bonewald LF, Seavey BK, VanderLaan WP. An interchain disulfide dimer of human growth hormone. J Biol Chem 1977; 252: 3697.

    PubMed  CAS  Google Scholar 

  20. Benveniste R, Stachura ME, Szabo M, Frohman LA. Big growth hormone (GH): conversion to small GH without peptide bond cleavage. J Clin Endocrinol Metab 1975; 41: 422.

    Article  PubMed  CAS  Google Scholar 

  21. Schneider AB, Kowalski K, Russell J, Sherwood LM. Identification of the interchain disulfide bonds of dimeric human placental lactogen. J Biol Chem 1979; 254: 3782.

    PubMed  CAS  Google Scholar 

  22. Tokunaga T, Tanaka T, Ikehara M, Ohtsuka E. Synthesis and expression of a human growth hormone (somatotropin) gene mutated to change cysteine-165 to alanine. Eur J Biochem 1985; 153: 445.

    Article  PubMed  CAS  Google Scholar 

  23. Dixon JS, Li CH. Retention of the biological potency of human pituitary growth hormone after reduction and carbamidomethylation., Science 1966; 154: 785.

    Article  PubMed  CAS  Google Scholar 

  24. Lewis UJ, Singh RNP, Bonewald LF, Seavey BK. Altered proteolytic cleavage of human growth hormone as a result of deamidation. J Biol Chem 1981; 256: 1 1645.

    Google Scholar 

  25. Lewis UJ, Singh RNP, Bonewald LF, Lewis LJ, VanderLaan WP. Human growth hormone: additional members of the complex. Endocrinology 1979; 104: 1256.

    Article  PubMed  CAS  Google Scholar 

  26. Liberti JP, Antoni BA, Chlebowski JF. Naturally-occurring pituitary growth hormone is phosphorylated. Biochem Biophys Res Commun 1985; 128: 713.

    Article  PubMed  CAS  Google Scholar 

  27. Oetting WS, Tuazon PT, Traugh JA, Walker AM. Phosphorylation of prolactin. J Biol Chem 1986; 261: 1649.

    PubMed  CAS  Google Scholar 

  28. Sinha YN, Lewis UJ. A lectin-binding immunoassay indicates a possible glycosylated growth hormone in the human pituitary gland. Biochem Biophys Res Commun 1986; 140: 491.

    Article  PubMed  CAS  Google Scholar 

  29. Lewis UJ, Singh RNP, Lewis LJ, Seavey BK, Sinha YN. Glycosylated ovine prolactin. Proc Natl Acad Sci USA 1984; 81: 385.

    Article  PubMed  CAS  Google Scholar 

  30. Pankov YuA, Butnev VYu. Multiple forms of pituitary prolactin. Glycosylated form of prolactin with enhanced biological activity. Int J Pept Protein Res 1986; 28: 113.

    Article  PubMed  CAS  Google Scholar 

  31. Meuris S, Svoboda M, Christophe J, Robyn C. Evidence for a glycosylated prolactin variant in human pituitary and amniotic fluid. In: MacLeod RM, Thorner MO, Scapagnini U, eds. Prolactin, basic and clinical correlates. Padova: Livana Press, 1985: 487 – 93.

    Google Scholar 

  32. Lewis UJ. Variants of growth hormone and prolactin and their post- translational modifications. Annu Rev Physiol 1984; 46: 33.

    Article  PubMed  CAS  Google Scholar 

  33. Laemmli UK. Cleavage of structural proteins during assembly of the head of bacteriophage T. Nature 1970; 227: 680.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Plenum Press, New York

About this chapter

Cite this chapter

Lewis, U.J., Singh, R.N.P., Lewis, L.J., Abadi, N. (1988). Multiple Forms of Growth Hormone. In: Bercu, B.B. (eds) Basic and Clinical Aspects of Growth Hormone. Serono Symposia, USA. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5505-2_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5505-2_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5507-6

  • Online ISBN: 978-1-4684-5505-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics